Skip to content
DataLookout
Menu

NCT06522828

A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients

StatusUnknown
PhasePhase 2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 2024 to Oct 10, 2024
    • Study site revised
    v3
  3. Minor Study title shortened, about 2 wordsv2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

ORR
Timeframe: 12 months
Safety and tolerability
Timeframe: 12 months

Secondary (1)

PFS

Arms and interventions

SSGJ-707(dose 1)+ carboplatin + paclitaxelExperimental
SSGJ-707(dose 2)+ carboplatin + paclitaxelExperimental
SSGJ-707(dose 3)+ carboplatin + paclitaxelExperimental
SSGJ-707(dose 4)+ paclitaxelExperimental

Drugs: SSGJ-707, carboplatin, paclitaxel

Sites

1 site in 1 country

  • Chongqing Cancer HospitalChongqing, China